Trial intelligence / Profile preview

Phenotypic and genotypic characterization of tension-type headache and response to mirtazapine

2016-003846-97Phase 2Terminated

Sponsor
Aarhus University
Start
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of mirtazapine in tension-type headache (TTH), sponsored by Aarhus University. Primary endpoint: Headache days and severity. Started Oct 2016; status: terminated.

02

Drugs

mirtazapine
03

Conditions

tension-type headache (TTH)

Beyond the preview

Go deeper on 2016-003846-97.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003846-97.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call